Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Lepr Rev ; 75(1): 67-78, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15072128

RESUMO

Decentralization policies are an integrated component of health sector reform in an increasing number of countries. The ability of such policies to improve the health system's quality and efficiency is backed up by limited scientific evidence. This study intends to evaluate the impact of decentralization on a specialized field of disease control (leprosy control) in Colombia and Brazil. It analyses the respective juridical base, epidemiological indicators and local publications. Furthermore, 39 semi-structured interviews with key informants were conducted. In both countries, the devolution of technical responsibility and financial resources to the municipalities was the implemented form of decentralization. Access to preventive and curative health care and the community participation in decision-making improved clearly only in Brazil. The decentralization to private providers in Colombia had dubious effects on service quality in general and still more on public health. The flow of finances (including finance collection through state-owned taxes instead of insurance companies) seemed to be better controlled in Brazil. Leprosy control in Brazil took advantage of the decentralization process; in Colombia, it came close to a collapse.


Assuntos
Controle de Doenças Transmissíveis/organização & administração , Hanseníase/prevenção & controle , Programas Nacionais de Saúde/normas , Política , Brasil/epidemiologia , Colômbia/epidemiologia , Feminino , Reforma dos Serviços de Saúde , Humanos , Hanseníase/epidemiologia , Governo Local , Masculino , Programas Nacionais de Saúde/tendências , Avaliação de Resultados em Cuidados de Saúde , Formulação de Políticas , Medição de Risco
2.
J Am Acad Dermatol ; 49(2 Suppl Case Reports): S170-3, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12894113

RESUMO

We describe a 58-year-old man presenting with necrotizing panniculitis of the lower right leg and a 64-year-old woman with a clinically similar lesion combined with pustular eruptions and subsequent ulceration on the forehead. In the first patient, Giemsa staining showed small ovoid bodies and Grocott staining revealed hyphae. Histology from the process on the forehead showed branched filaments in the periodic acid-Schiff (PAS) staining. In the first case, Madurella mycetomatis, a fungus, was the pathogenic agent, whereas in the other case white colonies of filamentous organisms resembling fungi could be cultivated that turned out to be the bacterium Nocardia brasiliensis. Since the initial clinical appearance of these two forms of mycetoma were almost identical and histopathologic findings were inconclusive, only sophisticated microbiologic work-up of material from lesional skin led to the correct diagnosis. In times of global tourism, these unusual cases impressively document the necessity to become more familiar with mycetoma to make accurate therapeutic decisions with effective results, possibly saving a limb.


Assuntos
Dermatomicoses/diagnóstico , Madurella/isolamento & purificação , Micetoma/diagnóstico , Paniculite/patologia , Antifúngicos/administração & dosagem , Biópsia por Agulha , Terapia Combinada , Dermatomicoses/terapia , Diagnóstico Diferencial , Dermatoses Faciais/microbiologia , Dermatoses Faciais/terapia , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Extremidade Inferior , Masculino , Pessoa de Meia-Idade , Micetoma/terapia , Necrose , Paniculite/microbiologia , Medição de Risco , Índice de Gravidade de Doença , Procedimentos Cirúrgicos Operatórios/métodos , Resultado do Tratamento
3.
Clin Infect Dis ; 37(2): e19-21, 2003 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-12856229

RESUMO

Murray Valley encephalitis (MVE) is an important mosquitoborne flavivirus infection endemic to Australia and Papua New Guinea. We report the first imported case of MVE in Europe. A 23-year-old tourist developed severe encephalitis after having returned to Germany from a long-term trip across the Australian continent. The diagnosis was suspected on the basis of clinical findings and the patient's travel history and was confirmed by serological findings. The patient made a prolonged but complete recovery. Our case coincides with a recently reported spread of MVE virus in Australia. This emphasizes the need for continuous surveillance in areas of endemicity and appropriate protection when traveling through regions in which the MVE virus is endemic.


Assuntos
Vírus da Encefalite do Vale de Murray , Encefalite por Arbovirus/transmissão , Adulto , Antivirais/uso terapêutico , Austrália/epidemiologia , Encefalite por Arbovirus/tratamento farmacológico , Encefalite por Arbovirus/epidemiologia , Encefalite por Arbovirus/imunologia , Alemanha/epidemiologia , Humanos , Masculino , Papua Nova Guiné/epidemiologia , Viagem
4.
Clin Infect Dis ; 36(10): 1254-8, 2003 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-12746770

RESUMO

This study sought to assess the risk of secondary transmission after import of Lassa fever into Europe. A total of 232 persons exposed to a case of Lassa fever imported into Germany were identified. The level of exposure was determined for 157 persons (68%), and 149 (64%) were tested serologically. High-risk or close contact was reported by 30 (19%) of 157 persons. No symptomatic secondary infections were observed. However, Lassa virus-specific immunoglobulin G antibodies were detected in a serum sample obtained from a physician who examined the index patient on day 9 of illness. The physician received ribavirin prophylaxis and did not develop symptoms of Lassa fever. On the basis of these data, the contact was classified as having a probable secondary infection. The study indicates a low risk of transmission during the initial phase of symptomatic Lassa fever, even with high-risk exposures. The risk may increase with progression of disease and increasing virus load.


Assuntos
Anticorpos Antivirais/imunologia , Febre Lassa/transmissão , Vírus Lassa/imunologia , Animais , Antivirais/uso terapêutico , Quimioprevenção , Alemanha/epidemiologia , Humanos , Imunoglobulina G/imunologia , Febre Lassa/epidemiologia , Febre Lassa/imunologia , Febre Lassa/prevenção & controle , Vírus Lassa/efeitos dos fármacos , Ribavirina/uso terapêutico , Gestão de Riscos
6.
Trans R Soc Trop Med Hyg ; 96(2): 178-9, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12055809

RESUMO

Tanapox is a rare pox disease endemic in East Africa. We report the first case of tanapox in a European traveller who contracted the disease in 1999 during a short visit to Tanzania. The diagnosis was made on clinical grounds and confirmed by electron microscopy and a tanapox virus-specific PCR assay.


Assuntos
Infecções por Poxviridae/diagnóstico , Dermatopatias Virais/diagnóstico , Infecções Tumorais por Vírus/diagnóstico , Yatapoxvirus , Europa (Continente) , Humanos , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase/métodos , Viagem
7.
Microbes Infect ; 4(1): 43-50, 2002 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11825774

RESUMO

During 2000, four cases of fatal Lassa fever were imported from Africa to Europe. In two patients, consecutive serum samples were available for monitoring of virus load and cytokine levels in addition to standard laboratory data. Both patients had non-specific early clinical symptoms including high fever. Patient 1 developed multi-organ failure and died of hemorrhagic shock on day 15 of illness, while patient 2 died of respiratory failure due to aspiration without hemorrhage on day 16. Ribavirin was administered to both patients beginning only on day 11. High serum aspartate aminotransferase and lactate dehydrogenase (LDH) levels were remarkable in both patients. Patient 1 had an initial virus load of 10(6) S RNA copies/ml as measured by real-time RT-PCR. Viremia increased steadily and reached a plateau of approximately 10(8)-10(9) copies/ml 4 days before death, while IFN-gamma and TNF-alpha rose to extremely high levels only shortly before death. In contrast, in patient 2 the virus load decreased from 10(7) to 10(6) copies/ml during the late stage of illness which was paralleled by a decrease in the IFN-gamma and TNF-alpha levels. The IL-10 level increased when specific IgM and IgG appeared. These data suggest that a high virus load and high levels of pro-inflammatory cytokines in the late stage of Lassa fever play an important role in the pathogenesis of hemorrhage, multi-organ failure, and shock in Lassa fever.


Assuntos
Febre Lassa/fisiopatologia , Febre Lassa/virologia , Vírus Lassa , Adulto , África , Anticorpos Antivirais/sangue , Antivirais/uso terapêutico , Citocinas/metabolismo , Evolução Fatal , Feminino , Humanos , Febre Lassa/diagnóstico , Febre Lassa/tratamento farmacológico , Vírus Lassa/genética , Vírus Lassa/isolamento & purificação , Vírus Lassa/fisiologia , Masculino , Pessoa de Meia-Idade , RNA Viral/sangue , Ribavirina/uso terapêutico , Viagem , Carga Viral , Viremia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...